Evidence map›Paper›PMID 29712659›Full record

ArticleAntimicrobial agents and chemotherapy2018

Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae of Sequence Type 36.

Yu Feng, Yang Lu, Zhihong Yao, Zhiyong Zong

Registry-linked trialAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05932355 (Assessment of the Effect of Plasmid Inhibitors and Antimicrobial Drugs as Combined Strategy Against Clinical Multi-drug Resistant Hypervirulent Klebsiella Pneumoniae), which is not on this map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05932355 unknown statusnot on this mapstarted 2023, after this paper: background citation

Assessment of the Effect of Plasmid Inhibitors and Antimicrobial Drugs as Combined Strategy Against Clinical Multi-drug Resistant Hypervirulent Klebsiella Pneumoniae

TypeobservationalSponsorAssiut UniversityRan2023 to 2025Enrolled50ConditionsSynergy Between Plasmid Inhibitors and Combined Antibiotics
3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Hypervirulent and Drug-ResistantInternational journal of general medicine · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. HypervirulentPharmaceuticals (Basel, Switzerland) · 2025
    Review
  10. Prevalence, Risk Factors, and Clinical Outcomes of HypervirulentIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2025
    Article
  11. Molecular and genetic features of a blaAnnals of clinical microbiology and antimicrobials · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Microbiology spectrum · 2024
    Article
  18. Article
  19. Article
  20. Coexistence of tet(A) and blaEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu Feng *Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Yang Lu *Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Zhihong YaoCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Zhiyong ZongCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China zongzhiy@scu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sequence type 36 (ST36)

Indexed as

Anti-Bacterial AgentsBacterial ProteinsCarbapenem-Resistant EnterobacteriaceaeKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsMultilocus Sequence TypingVirulenceAnti-Bacterial AgentsBacterial Proteinscarbapenem resistancehypervirulenceKlebsiella pneumoniae

Identifiers

PMID29712659
PMCPMC6021629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.